pwC
Nigerian agency strongly contests that 70% of drugs are fake
November 13, 2017Manufacturing and Production, Sales and Marketing Nigeria, biotech, drugs, pharma, pharmaceutical, pwC
Nigeria’s drug regulatory body has fiercely countered claims made by Chief Economist of PwC in West Africa, Andrew Nevin, that …
AZ tops annual R&D spend in UK, Roche is greatest pharma spender worldwide
October 24, 2017Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, GSK, GlaxoSmithKline, R&D, Roche, pwC
New findings of a report by PwC have revealed the biggest spenders in R&D worldwide as global spending hits $700 …
PwC appoints Issy Corbett as healthcare M&A partner
February 1, 2016Sales and Marketing pwC
PwC has appointed Issy Corbett as a partner to lead its healthcare M&A team.Corbett joins PwC from Rothschild, where he …
Adaptimmune appoints PwC head to board
March 12, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lawrence Alleva, adaptimune, pwC
Clinical-stage biotech firm Adaptimmune has appointed Lawrence Alleva as a non-executive director who is also to serve as chairman of its …
Actavis hires senior head from PwC
December 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Jonathon Kellerman, pwC
Jonathon Kellerman has joined Ireland-based speciality pharma firm Actavis as its executive vice president and global chief compliance officer. Reporting …
Consumers want more from wearables market
November 6, 2014Medical Communications, Sales and Marketing Apple, Microsoft, Samsung, mhealth, pwC, watch, werables
The interest in mobile health (mHealth) wearables is gaining traction, but consumers want more affordable devices that offer greater engagement …
The future is bright – but don’t rely on emerging markets
November 16, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, emerging markets, industry, pwC
The pharma industry could be “on the cusp of a golden era” of renewed productivity and earnings – but only …
Turkey ‘can be pharma R&D, production hub by 2023’, says PwC
October 23, 2012Manufacturing and Production, Research and Development, Sales and Marketing R&D, Turkey, pwC
Despite lagging behind its peers among ‘pharmerging’ economies, Turkey has the potential to become a major R&D and production hub …
1 in 3 surveyed says social media changes attitudes to medicines
April 20, 2012Business Services, Medical Communications, Sales and Marketing Facebook, Twitter, digital, pwC, social networking
A third of US social media users say it could change the way they think about their medicines, according to …
Pharma must rethink manufacturing, says PwC
February 22, 2011Manufacturing and Production pharma manufacturing, pricewaterhousecoopers, pwC
The pharmaceutical industry needs to undertake a radical overhaul in its approach to manufacturing which at present is “inefficient, under-utilised …
US healthcare ‘extreme makeover’ predicted for 2011
December 31, 2010Sales and Marketing US, US health reforms, US healthcare, health organisations, pricewaterhousecoopers, pwC
Health organisations in the US will undergo a strategic makeover in 2011 as they react to the pressures from new …
Pharma must go further with its collaborations
May 8, 2009Research and Development, Sales and Marketing pwC, strategy
Pharma companies will soon have to start collaborating with companies outside the healthcare sector.The global economic situation will make this …
Time running out for pharma sales and marketing
February 26, 2009Research and Development, Sales and Marketing pwC, strategy
The pharma industry's current sales and marketing model will be defunct in the next ten years. That is the stark …
